Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
Titel:
Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
Auteur:
Bao, Philip Q. Ramanathan, Ramesh K. Krasinkas, Alyssa Bahary, Nathan Lembersky, Barry C. Bartlett, David L. Hughes, Steven J. Lee, Kenneth K. Moser, A. James Zeh, Herbert J.